Jiyao Sheng

2.3k total citations · 1 hit paper
47 papers, 1.7k citations indexed

About

Jiyao Sheng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiyao Sheng has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiyao Sheng's work include Pancreatic and Hepatic Oncology Research (6 papers), RNA modifications and cancer (6 papers) and Cancer Mechanisms and Therapy (4 papers). Jiyao Sheng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), RNA modifications and cancer (6 papers) and Cancer Mechanisms and Therapy (4 papers). Jiyao Sheng collaborates with scholars based in China, Japan and United States. Jiyao Sheng's co-authors include Xuewen Zhang, Ranji Cui, Liu Shui, Yicun Wang, Hanjiao Qin, Bingjin Li, Shui Liu, Dan Zhang, Jun Lin and Ziyong Cheng and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Jiyao Sheng

43 papers receiving 1.7k citations

Hit Papers

The Link between Depression and Chronic Pain: Neural Mech... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
    2017 516 citations Jiyao Sheng, Liu Shui et al. Neural Plasticity profile →

Peers

Jiyao Sheng
Jijun Li China
Há Thi Nguyen Vietnam
Yan Jiang China
Patrizia Ballerini Italy
Alireza Pasdar Iran
Rui Gao China
Xian Wang China
Liqun Wang China
Jianhong Wang China
Jijun Li China
Jiyao Sheng
Citations per year, relative to Jiyao Sheng Jiyao Sheng (= 1×) peers Jijun Li

Countries citing papers authored by Jiyao Sheng

Since Specialization
Citations

This map shows the geographic impact of Jiyao Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyao Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyao Sheng more than expected).

Fields of papers citing papers by Jiyao Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyao Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyao Sheng. The network helps show where Jiyao Sheng may publish in the future.

Co-authorship network of co-authors of Jiyao Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyao Sheng. A scholar is included among the top collaborators of Jiyao Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyao Sheng. Jiyao Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Hanjiao, et al.. (2025). Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. International Journal of Nanomedicine. Volume 20. 13255–13292.
2.
Liu, Yufan, et al.. (2025). New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis. Frontiers in Immunology. 16. 1741398–1741398.
3.
Wang, Zhanshan, Jiyao Sheng, & Xuewen Zhang. (2025). Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess. Scientific Reports. 15(1). 16188–16188. 1 indexed citations
4.
Han, Xi, Zefeng Liu, Jie Lin, et al.. (2024). FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway. Aging. 16(19). 12806–12819. 5 indexed citations
5.
Sheng, Li, Jiyao Sheng, Dan Zhang, & Hanjiao Qin. (2024). Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. 16(11). 10165–10196. 4 indexed citations
6.
Sheng, Jiyao, et al.. (2023). Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension. Hepatobiliary & pancreatic diseases international. 23(1). 4–13. 1 indexed citations
7.
Zhong, Jianfeng, et al.. (2022). Advances in Renal Cell Carcinoma Drug Resistance Models. Frontiers in Oncology. 12. 870396–870396. 15 indexed citations
8.
Liu, Zefeng, Lu Jin, Fang He, et al.. (2021). m6A Modification-Mediated DUXAP8 Regulation of Malignant Phenotype and Chemotherapy Resistance of Hepatocellular Carcinoma Through miR-584-5p/MAPK1/ERK Pathway Axis. Frontiers in Cell and Developmental Biology. 9. 783385–783385. 27 indexed citations
9.
Liu, Shui, Yan Cai, E Changyong, Jiyao Sheng, & Xuewen Zhang. (2021). Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer. Pathology & Oncology Research. 27. 1609868–1609868. 11 indexed citations
10.
Wang, Yicun, Jiyao Sheng, Cuilin Zhu, et al.. (2021). Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy. Frontiers in Immunology. 12. 729336–729336. 15 indexed citations
11.
Sheng, Jiyao, Guangquan Li, Yicun Wang, et al.. (2020). Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review. Frontiers in Pharmacology. 10. 1461–1461. 82 indexed citations
12.
Lin, Chao, et al.. (2020). Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. Journal of Physiology and Biochemistry. 76(3). 469–481. 21 indexed citations
13.
Wu, Jiacheng, Jiyao Sheng, Mengying Cui, et al.. (2020). Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. Journal of Experimental & Clinical Cancer Research. 39(1). 267–267. 58 indexed citations
14.
Xie, Yingjun, Jiyao Sheng, Dan Zhang, et al.. (2018). Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations. Journal of Immunology Research. 2018. 1–8. 48 indexed citations
15.
Liu, Shui, Xiaoxiao Yao, Dan Zhang, et al.. (2018). Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma. BioMed Research International. 2018. 1–16. 26 indexed citations
16.
Sheng, Jiyao, Liu Shui, Yicun Wang, Ranji Cui, & Xuewen Zhang. (2017). The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plasticity. 2017. 1–10. 516 indexed citations breakdown →
17.
Sheng, Jiyao, Luyan Shen, Jing Su, et al.. (2017). Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS. PLoS ONE. 12(3). e0173712–e0173712. 75 indexed citations
18.
19.
Fu, Pei‐Yao, Fan Yang, Bo Li, et al.. (2016). Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis. Digestive and Liver Disease. 49(1). 77–83. 3 indexed citations
20.
Xu, Guangyu, Bin Liu, Fang Wang, et al.. (2013). High-throughput screen of essential gene modules in Mycobacterium tuberculosis: a bibliometric approach. BMC Infectious Diseases. 13(1). 227–227. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jijun Li Breakdown of academic impact, for papers by Há Thi Nguyen Breakdown of academic impact, for papers by Yan Jiang Breakdown of academic impact, for papers by Patrizia Ballerini Breakdown of academic impact, for papers by Alireza Pasdar Breakdown of academic impact, for papers by Rui Gao Breakdown of academic impact, for papers by Xian Wang Breakdown of academic impact, for papers by Liqun Wang Breakdown of academic impact, for papers by Jianhong Wang
Rankless by CCL
2026